
Mercado das enxaquecas: produtos e diagnósticos
A Impel Pharmaceuticals refere que se espera que o mercado da enxaqueca nos EUA cresça a uma taxa de crescimento anual composta de 9,9%, atingindo
A Impel Pharmaceuticals refere que se espera que o mercado da enxaqueca nos EUA cresça a uma taxa de crescimento anual composta de 9,9%, atingindo
Impel Pharmaceuticals indique que le marché américain de la migraine devrait connaître un taux de croissance annuel composé de 9,9%, pour atteindre 12 milliards de
Impel Pharmaceuticals refers that the U.S. migraine market is forecast to grow at a compound annual growth rate of 9.9%, reaching $12 billion by 2030,
Impel Pharmaceuticals refiere que el mercado de la migraña en Estados Unidos crezca previsiblemente a una tasa compuesta anual de 9.9%, alcanzando los 12,000 millones
A Impel Pharmaceuticals refere que se espera que o mercado da enxaqueca nos EUA cresça a uma taxa de crescimento anual composta de 9,9%, atingindo
Impel Pharmaceuticals indique que le marché américain de la migraine devrait connaître un taux de croissance annuel composé de 9,9%, pour atteindre 12 milliards de
Impel Pharmaceuticals refers that the U.S. migraine market is forecast to grow at a compound annual growth rate of 9.9%, reaching $12 billion by 2030,
Impel Pharmaceuticals refiere que el mercado de la migraña en Estados Unidos crezca previsiblemente a una tasa compuesta anual de 9.9%, alcanzando los 12,000 millones
info@opportimes.com